Cascadian Therapeutics, Inc. Interest Expense
Cascadian Therapeutics, Inc. reported Interest Expense of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-10.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2015-03-10
- Cascadian Therapeutics, Inc. interest expense for fiscal 2014 was $0.00.
- Cascadian Therapeutics, Inc. interest expense for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Cascadian Therapeutics, Inc. interest expense for fiscal 2012 was $308.75K.
| Period end | Interest Expense 12 month |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-10 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-10 |
| 2012-12-31 | $308.75K 10-K · filed 2015-03-10 |